Secukinumab (anti-IL-17A)
Product Specifications
CAS Number
1229022-83-6
Synonyms
AIN457
SKU
C14602-5mg
Target
Interleukins
Applications
Immunology & Inflammation
Additionnal Information
Secukinumab (anti-IL-17A) (AIN457) is a human IgG1κ monoclonal antibody that binds to the protein interleukin (IL) -17A, and is applied for the treatment of psoriasis, ankylosing spondylitis, and psoriatic arthritis. MW=147.9 kDa.
Storage Conditions
Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
351703-01 48 Tests
TGFBI BioAssayTM ELISA Kit (Mouse) (Transforming Growth Factor-beta-induced Protein ig-h3, BIGH3, CDB1, CDG2, CDGG1, CSD, CSD1, CSD2, CSD3, EBMD, LCD1, RGD-containing Collagen-associated Protein, Kerato-epithelin)
Sign In for Pricing
View Details 351703-02 96 Tests
TGFBI BioAssayTM ELISA Kit (Mouse) (Transforming Growth Factor-beta-induced Protein ig-h3, BIGH3, CDB1, CDG2, CDGG1, CSD, CSD1, CSD2, CSD3, EBMD, LCD1, RGD-containing Collagen-associated Protein, Kerato-epithelin)
Sign In for Pricing
View Details 